tiprankstipranks
Bionik Laboratories Corp (BNKL)
OTHER OTC:BNKL
US Market

Bionik Laboratories (BNKL) Income Statement

Compare
9 Followers

Bionik Laboratories Income Statement

Last quarter (Q2 2024), Bionik Laboratories's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, Bionik Laboratories's net income was $0.00. See Bionik Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 23Mar 22Mar 21Mar 20Mar 19
Total Revenue
$ 1.81M$ 1.27M$ 1.19M$ 2.15M$ 3.25M
Gross Profit
$ 989.88K$ 953.26K$ 923.80K$ 1.26M$ 1.62M
Operating Expenses
$ 5.81M$ 5.73M$ 7.08M$ 12.42M$ 11.10M
Depreciation and Amortization
$ 63.17K$ 102.62K$ 189.73K$ 380.65K$ 348.21K
EBITDA
$ -4.78M$ -9.48M$ -13.03M$ -24.64M$ -6.94M
Operating Income
$ -4.83M$ -4.77M$ -6.16M$ -11.25M$ -7.29M
Other Income/Expenses
$ -120.98K$ -5.64M$ -7.47M$ -13.77M$ -1.07M
Pretax Income
$ -4.95M$ -10.41M$ -13.62M$ -25.02M$ -10.56M
Net Income
$ -4.95M$ -15.61M$ -13.96M$ -24.93M$ -10.56M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.72$ -2.67$ -2.72$ -5.60$ -4.47
Diluted EPS
$ -0.72$ -2.67$ -2.72$ -5.60$ -4.47
Weighted Average Shares Outstanding
6.90M 5.84M 5.13M 4.46M 2.36M
Weighted Average Shares Outstanding (Diluted)
6.90M 5.84M 5.13M 4.46M 2.36M
Currency in USD

Bionik Laboratories Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis